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Background: Half dose Pre-Hospital Fibrinolytic therapy followed by urgent PCI reduces ischemic time and infarct size in STEMI patients without 
a bleeding penalty. Microvascular obstruction (MVO) predicts a lack of functional recovery in the infarct zone and poor cardiovascular outcome in 
patients with STEMI. We evaluated MVO and infarct size by cardiac MRI and cardiac biomarkers in quartiles of ischemic time to determine the time 
frame resulting in the least MVO and infarct size.
Methods: Data from patients enrolled in the PATCAR trial (Pre-Hospital Administration of Thrombolytic Therapy with Urgent Culprit Artery 
Revascularization) were analyzed. All patients received pre-hospital fibrinolytics followed by emergent PCI. Cardiac MRI was performed 3-5 days post 
revascularization. A total of 76 patients were evaluated for differences in MVO and infarct size. Ischemic time quartiles were: ≤ 110 minutes (Q1), 
111-140 minutes (Q2), 141-185 minutes (Q3) and > 185 minutes (Q4).
Results: Patients representing Q1 had significantly reduced MVO (MVO/LV Mass, %) and infarct sizes when compared with all other time quartiles 
(Q2-4). Cardiac biomarkers were also significantly reduced in the first quartile (see Table). There were no significant differences between quartiles in 
ejection fraction.
Conclusion: In patients with STEMI, the maximum benefit as assessed by infarct size and MVO is obtained if the myocardium is reperfused within 
the first 110 minutes of transmural ischemia.
*P values for comparisons between Q1 and each individual other quartile (Q2-4).
Variable Q1 (≤ 110 min)n=17 Q2 (111-140 min)*n=20 Q3 (141-185 min)*n=19 Q4 (> 185 min)*n=20
Ischemic Time (min) 95.41 ± 9.1 123.65 ± 8.6 163.42 ± 15.4 255.95 ± 78.1
MVO/LV Mass, % 0.20 ± 0.4
0.69 ± 0.6
P=0.006
0.83 ± 1.3
P=0.049
0.82 ± 1.1
P=0.028
MRI Infarct Size, % 5.41 ± 5.7
10.72 ± 8.3
P=0.028
11.82 ± 7.2
P=0.005
9.71 ± 5.6
P=0.027
Peak 24 hour CK, U/L 1206.06 ± 1099.9
2271.25 ± 1648.8
P=0.025
2615.84 ± 1945.2
P=0.011
2136.65 ± 1713.5
P=0.055
Peak 24 hour Troponin T, ng/mL 4.44 ± 4.9
8.39 ± 6.0
P=0.034
10.33 ± 9.2
P=0.024
8.40 ± 5.2
P=0.022
Peak 24 hour CK-MB, ng/mL 108.03 ± 95.3
213.20 ± 133.8
P=0.010
240.66 ± 207.4
P=0.022
183.99 ± 127.7
P=0.049
Ejection Fraction, % 54.64 ± 11.7
50.51 ± 13.8
P=0.338
48.10 ± 5.7
P=0.054
51.74 ± 12.4
P=0.494
